A 2006 article published online by the Annals of Internal Medicine on January 20, 2006 reported that Ketek (telithromycin), an antibiotic used for serious respiratory and other drug-resistant infections, has been linked to serious liver damage in three patients in the Carolinas Medical Center in Charlotte, North Carolina. More recent reports to the FDA (Food and Drug Administration) support that finding. The drug may be linked to the following Ketek side effects:
The FDA (Food and Drug Administration) issued a MedWatch Alert on its website on the day this article appeared. The FDA Ketek alert was followed by a January 27, 2006 Ketek safety statement from the EMEA (European Medicines Agency) and a February 7, 2006 warning from Health Canada.
Patients taking Ketek and their health care providers are advised to watch for signs of liver problems while Ketek is taken. Symptoms of liver problems include jaundice, or the yellowing of the skin or eyes; loss of appetite; dark urine; pale stools; itching; and abdominal pain, particularly on the right side. Before you take Ketek you are advised to discuss the possibility of Ketek liver damage, Ketek liver failure, and Ketek drug-induced hepatitis with your health care provider.
If you have suffered liver damage, liver failure, or drug-induced hepatitis after taking Ketek, you may be entitled to recover damages for your injury.
Check out the following articles for more information about Ketek, filing a Ketek lawsuit and finding a Ketek attorney.
To learn more about dangerous drugs and the law, go to FreeAdvice.com.